Description
Allergic rhinitis is both common and burdensome. It reduces quality of life, school and work performance, and increases healthcare seeking. Furthermore, allergic rhinitis is increasingly recognized as an immunoglobulin E-mediated inflammatory condition that is strongly associated with asthma, with implications for both the development and the management of asthma.
New treatments and new evidence have emerged in recent years, prompting the update of major clinical practice guidelines in North America and Europe. This program reviews current updates in the recommendations for management of allergic rhinitis and supports clinicians in optimizing symptom control through individualized therapy for their patients.